NCT02831231View on ClinicalTrials.gov

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 7, 2016

Primary Completion Date

October 28, 2016

Study Completion Date

October 28, 2016

Conditions
Schizophrenia
Interventions
DRUG

xanomeline tartrate

xanomeline tartrate, 75 mg capsule, TID

DRUG

Trospium chloride

trospium chloride, over encapsulated 20 mg tablet, BID

Trial Locations (1)

45227

Medpace, Cincinnati

Sponsors
All Listed Sponsors
lead

Karuna Therapeutics

INDUSTRY

NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium | Biotech Hunter | Biotech Hunter